Plasma levels of CHI3L1, GDF-15, IGFBP-2, MIF, ST2, TFF3, and uPAR were significantly higher in SLE patients compared with healthy volunteers (Figure 1(c)). This evidence concerns the gene IGFBP2 and systemic lupus erythematosus.